Updates
Regulatory Framework for Cannabis: A Position Paper from the American College of Physicians
Public policy on cannabis is changing rapidly as several states have legalized the drug for medical and recreational use even though its possession, use, and distribution remain illegal under federal law. In 2008, the American College of Physicians (ACP) published...
Alcohol Consumption Patterns and Mortality Among Older Adults with Health-Related or Socioeconomic Risk Factors
This British study included 135,103 older (median age 64) adults and compared drinking patterns with mortality during a median follow-up of 12 years. Compared to occasional drinkers, low-risk drinkers had higher cancer mortality, moderate-risk drinkers had higher...
Results from the 2023 National Survey on Drug Use and Health
This report provides key findings from the 2023 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment among the noninstitutionalized U.S. population aged 12 or older. Estimates are presented by age group and by race/ethnicity...
‘Life-changing Support’: NC Program for Substance Use Disorder Through Pregnancy and Beyond
Jessie Greenblatt calls her hometown of Hendersonville, in the Blue Ridge Mountains of Western North Carolina, “a very quaint little town.” But, oh, how she’s seen it suffer. A woman Greenblatt went to high school with hosts a Facebook page that serves as a memorial...
New July 2024 NC Statewide Overdose Surveillance Reports
The Injury and Violence Prevention Branch of the Division of Public Health (IVPB) recently posted an update of suspected overdose deaths, fentanyl-positive deaths, and provisional data on Emergency Department (ED) visits for overdose reports. While the year-to-date...
New Study: Extended-Release 7-Day Injectable Buprenorphine for Patients with Minimal to Mild Opioid Withdrawal
Buprenorphine is an effective yet underused treatment for opioid use disorder (OUD). Researchers set out with this objective – to evaluate the feasibility (acceptability, tolerability, and safety) of 7-day injectable extended-release buprenorphine in patients with...
Learn more about our conferences and educational opportunities
Addiction Medicine Spring and Fall Conferences provide up-to-date substance use related education, applicable across general medical as well as addiction specialty practices.